Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVP-I/Budesonide Gel Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis
NCT07383402Phase 3Not yet recruiting
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands, Hydrogel Systems
01
Overview
A Phase 3 trial of IVIEW-1502, EPI-EE in chronic rhinosinusitis (CRS). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
IVIEW-1502EPI-EE
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT07383402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07383402.